Nirmatrelvir-ritonavir reduced the risk for long COVID in adults aged 50 years and older but not in adolescents.
Interferon-α nasal spray was safe and effective in reducing COVID-19 risk by 40% in patients with cancer, demonstrating its potential as an additional preventive strategy alongside vaccines and ...
EXCLUSIVE: Tongal, the creators’ platform, is launching an animated series inspired by artwork from a patient at St. Jude ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback